Pfs230: From malaria transmission-blocking vaccine candidate toward function

Parasite Immunology

Volumn 25, Issue 7, 2003, Pages 351-359

  Williamson, Kim C ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Gametogenesis; Malaria; Plasmodium falciparum; Targeted gene disruption; Vaccine

Indexed keywords

GENE PRODUCT; MALARIA VACCINE; PROTEIN PFS230; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

DISEASE TRANSMISSION; GAMETOGENESIS; GENE DISRUPTION; GENE TARGETING; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CULICIDAE; FEMALE; GENES, PROTOZOAN; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 0347510965     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2003.00643.x     Document Type: Review

References (64)

1. Carter R & Chen DH. Malaria transmission blocked by immunisation with gametes of the malaria parasite. Nature, 1976; 263: 57-60.
2. Gwadz RW. Successful immunization against the sexual stages of Plasmodium gallinaceum. Science, 1976; 193: 1150-1151.
3. Gwadz RW, Carter R & Green I. Gamete vaccines and transmission-blocking immunity in malaria. Bull World Health Organization, 1979; 57: 175-180.
4. Gwadz RW & Green I. Malaria immunization in Rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi. J Exp Med, 1978; 148: 1311-1323.
5. Huff CG, Marchbank DF & Shiroishi T. Changes in infectiousness of malarial gametocytes. II. Analysis of the possible causative factors. Exp Parasitol, 1958; 7: 399-417.
6. Carter R, Gwadz RW & McAuliffe FM. Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte-and gamete-containing preparations. Exp Parasitol, 1979; 47: 185-193.
7. Carter R, Gwadz RW & Green I. Plasmodium gallinaceum: Transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection. Experimental Parasitology, 1979; 47: 203-210.
8. Rener J, Graves PM, Carter R, Williams JL & Burkot TR. Target antigens of transmission-blocking immunity on gametes of Plasmodium falciparum. J Exp Med, 1983; 158: 976-981.
9. Vermeulen AN, Ponnudurai T, Beckers PJ, Verhave JP, Smits MA & Meuwissen JH. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med, 1985; 162: 1460-1476.
10. Quakyi IA, Carter R, Rener J, Kumar N, Good MF & Miller LH. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J Immunol, 1987; 139: 4213-4217.
11. Read D, Lensen AH, Begarnie S, Haley S, Raza A & Carter R. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol, 1994; 16: 511-519.
12. Grotendorst CA, Kumar N, Carter R & Kaushal DC. A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies. Infection Immunity, 1984; 45: 775-777.
13. Kaushal DC, Carter R, Rener J, Grotendorst CA, Miller LH & Howard RJ. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes. J Immunol, 1983; 131: 2557-2562.
14. Duffy PE, Pimenta P & Kaslow DC. Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies. J Exp Med, 1993; 177: 505-510.
15. Kaslow DC, Quakyi IA, Syin C, et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature, 1988; 333: 74-76.
16. Feng Z, Hoffmann RN, Nussenzweig RS, et al. Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11·1 gene product. J Exp Med, 1993; 177: 273-281.
17. Wizel B & Kumar N. Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity. Proc Natl Acad Sci USA, 1991; 88: 9533-9537.
18. Ghosh AK, Moreira LA & Jacobs-Lorena M. Plasmodium-mosquito interactions, phage display libraries and transgenic mosquitoes impaired for malaria transmission. Insect Biochem Mol Biol, 2002; 32: 1325-1331.
19. Langer RC, Li F & Vinetz JM. Identification of novel Plasmodium gallinaceum zygote-and ookinete-expressed proteins as targets for blocking malaria transmission. Infection Immunity, 2002; 70: 102-106.
20. Langer RC, Li F, Popov V, Kurosky A & Vinetz JM. Monoclonal antibody against the Plasmodium falciparum chitinase, PfCHT1, recognizes a malaria transmission-blocking epitope in Plasmodium gallinaceum ookinetes unrelated to the chitinase PgCHT1. Infection Immunity, 2002; 70: 1581-1590.
21. Foo A, Carter R, Lambros C, et al. Conserved and variant epitopes of target antigens of transmission-blocking antibodies among isolates of Plasmodium falciparum from Malaysia. Am J Trop Med Hygiene, 1991; 44: 623-631.
22. Graves PM, Carter R, Burkot TR, Quakyi IA & Kumar N. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol, 1988; 10: 209-218.
23. Mulder B, Tchuinkam T, Dechering K, et al. Malaria transmission-blocking activity in experimental infections of Anopheles gambiae from naturally infected Plasmodium falciparum gametocyte carriers. Transactions Royal Soc for Trop Med Hygiene, 1994; 88: 121-125.
24. Mulder B, Tchuinkam T, Verhave JP & Robert V. Malaria transmission-blocking activity in the plasma of Plasmodium falciparum gametocyte carriers in Cameroon. Parasitologia, 1993; 35 (Suppl.): 65-67.
25. Ong CS, Zhang KY, Eida SJ, et al. The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates. Parasite Immunol, 1990; 12: 447-456.
26. Healer J, Graszynski A & Riley E. Phagocytosis does not play a major role in naturally acquired transmission-blocking immunity to Plasmodium falciparum malaria. Infection Immunity, 1999; 67: 2334-2339.
27. Premawansa S, Gamage-Mendis A, Perera L, Begarnie S, Mendis K & Carter R. Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka. Parasite Immunol, 1994; 16: 35-42.
28. Roeffen W, Beckers PJ, Teelen K, et al. Plasmodium falciparum a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs. Exp Parasitol, 1995; 80: 15-26.
29. Carter R, Graves PM, Quakyi IA & Good MF. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. J Exp Med, 1989; 169: 135-147.
30. Healer J, McGuinness D, Carter R & Riley E. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. Parasitology, 1999; 119: 425-433.
31. Roeffen W, Mulder B, Teelen K, et al. Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon. Parasite Immunol, 1996; 18: 103-109.
32. Williamson KC, Criscio MD & Kaslow DC. Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230. Mol Biochem Parasitol, 1993; 58: 355-358.
33. Elliott JF, Albrecht GR, Gilladoga A, et al. Genes for Plasmodium falciparum surface antigens cloned by expression in COS cells. Proc Natl Acad Sci USA, 1990; 87: 6363-6367.
34. Williamson KC, Keister DB, Muratova O & Kaslow DC. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol Biochem Parasitol, 1995; 75: 33-42.
35. Carter R, Coulson A, Bhatti S, Taylor BJ & Elliott JF. Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12. Mol Biochem Parasitol, 1995; 71: 203-210.
36. Templeton TJ & Kaslow DC. Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Mol Biochem Parasitol, 1999; 101: 223-227.
37. van Dijk MR, Janse CJ, Thompson J, et al. A central role for P48/45 in malaria parasite male gamete fertility. Cell, 2001; 104: 153-164.
38. Eksi S & Williamson KC. Male-specific expression of the paralog of malaria transmission-blocking target antigen Pfs230, PfB0400w. Molecular and Biochemical Parasitology; 2002; 122: 127-130.
39. Florens L, Washburn MP, Raine JD, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature, 2002; 419: 520-526.
40. Lasonder E, Ishihama Y, Andersen JS, et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature, 2002; 419: 537-542.
41. Kumar N. Target antigens of malaria transmission blocking immunity exist as a stable membrane bound complex. Parasite Immunol, 1987; 9: 321-335.
42. Brooks SR & Williamson KC. Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis. Mol Biochem Parasitol, 2000; 106: 77-82.
43. Williamson KC, Fujioka H, Aikawa M & Kaslow DC. Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate. Mol Biochem Parasitol, 1996; 78: 161-169.
44. Riley EM, Williamson KC, Greenwood BM & Kaslow DC. Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230. Parasite Immunol, 1995; 17: 11-19.
45. Riley EM, Bennett S, Jepson A, et al. Human antibody responses to Pfs230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated. Parasite Immunol, 1994; 16: 55-62.
46. Williamson KC & Kaslow DC. Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230. Molecular and Biochemical Parasitology, 1993; 62: 125-127.
47. Vincent AA, Fanning S, Caira FC & Williamson KC. Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid. Parasite Immunol, 1999; 21: 573-581.
48. Bustamante PJ, Woodruff DC, Oh J, Keister DB, Muratova O & Williamson KC. Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission- blocking immunity. Parasite Immunol, 2000; 22: 373-380.
49. Fanning SL, Czesny B, Sedegah M, et al. A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230. Vaccine, 2003; 21: 3228-3235.
50. Eksi S, Stump A, Fanning SL, Shenouda MI, Fujioka H & Williamson KC. Targeting and sequestration of truncated Pfs230 in an intraerythrocytic compartment during Plasmodium falciparum gametocytogenesis. Mol Microbiol, 2002; 44: 1507-1516.
51. Kocken CH, Jansen J, Kaan AM, et al. Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol Biochem Parasitol, 1993; 61: 59-68.
52. Grotendorst CA, Carter R, Rosenberg R & Koontz LC. Complement effects on the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. I. Resistance of zygotes to the alternative pathway of complement. J Immunol, 1986; 136: 4270-4274.
53. Grotendorst CA & Carter R. Complement effects of the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. II. Changes in sensitivity to complement-like factors during zygote development. J Parasitol, 1987; 73: 980-984.
54. Beaty BJ & Marquardt WC. In: The Biology of Disease Vectors. Niwot, CO: University Press of Colorado, 1996.
55. Noriega FG, Wang XY, Pennington JE, Barillas-Mury CV & Wells MA. Early trypsin, a female-specific midgut protease in Aedes aegypti. isolation, aminoterminal sequence determination, and cloning and sequencing of the gene. Insect Biochem Mol Biol, 1996; 26: 119-126.
56. Billingsley PF & Hecker H. Blood digestion in the mosquito, Anopheles stephensi Liston (Diptera: Culicidae). Activity and distribution of trypsin, aminopeptidase, and alpha-glucosidase in the midgut. J Med Entomol, 1991; 28: 865-871.
57. Dimopoulos G, Muller HM, Levashina EA & Kafatos FC. Innate immune defense against malaria infection in the mosquito. Current Opinion Immunol, 2001; 13: 79-88.
58. Bonnet S, Prevot G, Jacques JC, Boudin C & Bourgouin C. Transcripts of the malaria vector Anopheles gambiae that are differentially regulated in the midgut upon exposure to invasive stages of Plasmodium falciparum. Cellular Microbiol, 2001; 3: 449-458.
59. Christophides GK, Zdobnov E, Barillas-Mury C, et al. Immunity-related genes and gene families in Anopheles gambiae. Science, 2002; 298: 159-165.
60. Dimopoulos G, Christophides GK, Meister S, et al. Genome expression analysis of Anopheles gambiae: responses to injury, bacterial challenge, and malaria infection. Proc Natl Acad Sci USA, 2002; 99: 8814-8819.
61. Oduol F, Xu J, Niare O, Natarajan R & Vernick KD. Genes identified by an expression screen of the vector mosquito Anopheles gambiae display differential molecular immune response to malaria parasites and bacteria. Proc Natl Acad Sci USA, 2000; 97: 11397-11402.
62. Tahar R, Boudin C, Thiery I & Bourgouin C. Immune response of Anopheles gambiae to the early sporogonic stages of the human malaria parasite Plasmodium falciparum. EMBO J, 2002; 21: 6673-6680.
63. Vermeulen AN, van Deursen J, Brakenhoff RH, Lensen TH, Ponnudurai T & Meuwissen JH. Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures. Mol Biochem Parasitol, 1986; 20: 155-163.
64. Primakoff P & Myles DG. Penetration, adhesion, and fusion in mammalian sperm-egg interaction. Science, 2002; 296: 2183-2185.